Showing results (71-80 of 99) with videos related to
Sort By:
Pageof 10
Journal of Perinatal Medicine|April 15, 2000
The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiencyA K Høgåsen, I Overlie, T W Hansen, et al.Acta Paediatrica Scandinavica|August 1, 1991
Does VLDL-LDL-cholesterol in cord serum predict future level of lipoproteins?V Fønnebø, L B Dahl, P J Moe, et al.Pediatric Hematology and Oncology|January 1, 1988
Thyroid function in children after cytostatic treatment for acute leukemiaR Nygaard, K S Bjerve, S Kolmannskog, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.Pediatric Hematology and Oncology|January 1, 1987
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokineticsL Slørdal, S Kolmannskog, P J Moe, et al.Pediatric Hematology and Oncology|January 1, 1986
Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapyL Slørdal, S Kolmannskog, P S Prytz, et al.Leukemia Research|May 1, 1997
On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemiaH Seidel, R Nygaard, P J Moe, et al.Acta Paediatrica Scandinavica|May 1, 1979
Progeny of survivors of acute lymphocytic leukemiaP J Moe, M Lethinen, R Wegelius, et al.Pediatric Hematology and Oncology|March 1, 1994
Evaluation of serious adverse events in patients treated with protocols including methotrexate infusionsH Seidel, P J Moe, R Nygaard, et al.Acta Paediatrica (Oslo, Norway : 1992)|April 1, 1992
Cerebrospinal fluid exchange after intrathecal methotrexate overdose. A report of two casesA M Jakobson, A Kreuger, O Mortimer, et al.Pageof 10